Global ROCK1 deletion mice, as well as hemizygous ROCK1+/− mice, exhibited reduced cardiac fibrosis, and the development of cardiac hypertrophy was not affected after TAC or in response to angiotensin II treatment45,46. The gene discussed is AGT; the disease is cardiac hypertrophy.